ArticleThe Journal of antibiotics2018

Engineered production of kitasetalic acid, a new tetrahydro-β-carboline with the ability to suppress glucose-regulated protein synthesis.

Shohei Ueda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.